Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006942
Filing Date
2021-05-12
Accepted
2021-05-12 16:30:33
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20210331x10q.htm 10-Q 817053
2 EX-31.1 gbio-20210331ex31186ead2.htm EX-31.1 7037
3 EX-31.2 gbio-20210331ex3123bb25a.htm EX-31.2 7176
4 EX-32.1 gbio-20210331ex321875595.htm EX-32.1 3954
5 EX-32.2 gbio-20210331ex322b7e5b8.htm EX-32.2 3933
  Complete submission text file 0001558370-21-006942.txt   3727116

Data Files

Seq Description Document Type Size
6 EX-101.INS gbio-20210331.xml EX-101.INS 784403
7 EX-101.SCH gbio-20210331.xsd EX-101.SCH 25766
8 EX-101.CAL gbio-20210331_cal.xml EX-101.CAL 41999
9 EX-101.DEF gbio-20210331_def.xml EX-101.DEF 86623
10 EX-101.LAB gbio-20210331_lab.xml EX-101.LAB 241177
11 EX-101.PRE gbio-20210331_pre.xml EX-101.PRE 209257
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 21915551
SIC: 2834 Pharmaceutical Preparations